Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2003
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID miceEnrico Garaci, Stefano Aquaro, Caterina Lapenta, et al.
International Immunology|March 5, 2005
Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID miceCaterina Lapenta, Massimo Spada, Stefano M Santini, et al.
The Journal of Experimental Medicine|July 23, 2003
Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alphaCaterina Lapenta, Stefano M Santini, Mariantonia Logozzi, et al.
FEBS Letters|May 19, 2006
Differentiation of monocyte-derived dendritic cells is associated with upregulation and activation of Rac-1 small GTPaseAnna Maria Giammarioli, Lucrezia Gambardella, Maria Giovanna Quaranta, et al.
European Journal of Immunology|July 21, 2006
IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigensCaterina Lapenta, Stefano M Santini, Massimo Spada, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2009
In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanomaFrancesca Pellizzari Tregno, Andrea Sau, Silvia Pezzola, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2019
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccineCaterina Lapenta, Simona Donati, Francesca Spadaro, et al.
International Journal of Cancer|February 24, 2015
Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cellsEleni Anastasiadou, Neha Garg, Rachele Bigi, et al.
Scientific Reports|May 18, 2026
Nanoplastics impair antitumor NK and CD8⁺ T cell cytotoxicity and antiviral B cell antibody responses to SARS-CoV-2Stefano Maria Santini, Francesca Spadaro, Agostina Pietrantoni, et al.
Vaccines|September 28, 2024
Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)Caterina Lapenta, Stefano Maria Santini, Celeste Antonacci, et al.
Pageof 3